Showing
1 - 3
results of
3
for search '
Cannon CP
'
Skip to content
Home
Collections
High Impact Articles
Jawi Collection
Malay Medicine
Search Options
UiTM Open Access
Search by UiTM Scopus
Advanced Search
Search by Category
Discovery Service
Sources
UiTM Journals
List UiTM Journal in IR
Statistic
About
Open Access
Creative Commons Licenses
COKI | Malaysia Open Access
Report Technical
User Guide
Contact Us
Search Tips
FAQs
All Fields
Title
Author
Subject
Call Number
ISBN/ISSN
Tag
Find
Advanced
Author
Cannon CP
Showing
1 - 3
results of
3
for search '
Cannon CP
'
, query time: 0.05s
Refine Results
Sort
Relevance
Date Descending
Date Ascending
Call Number
Author
Title
1
Anacetrapib: potential for the prevention and treatment of coronary heart disease
by
Steen DL
,
Khera AV
,
Cannon
CP
Published 2013-04-01
Get full text
Article
2
The differential effects of ertugliflozin on glucosuria and natriuresis biomarkers: Prespecified analyses from VERTIS CV
by
Cannon
,
C.P
,
Cherney, D.Z.I
,
Cosentino, F.
,
Dagogo-Jack, S.
,
Frederich, R.
,
Liu, C.-C
,
Liu, J.
,
Maldonado, M.
,
Pong, A.
,
Pratley, R.E
,
VERTIS CV Investigators
Published 2022
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
3
Ertugliflozin, renoprotection and potential confounding by muscle wasting. Reply to Groothof D, Post A, Gans ROB et al [letter]
by
Cannon
,
C.P
,
Charbonnel, B.
,
Cherney, D.Z.I
,
Cosentino, F.
,
Dagogo-Jack, S.
,
Frederich, R.
,
Maldonado, M.
,
McGuire, D.K
,
on behalf of the VERTIS CV Investigators
,
Pong, A.
,
Pratley, R.
,
Shih, W.J
Published 2022
Call Number:
Loading...
Located:
Loading...
View Fulltext in Publisher
Article
Search Tools:
Get RSS Feed
—
Email this Search
Related Subjects
Biomarkers
Body Weight
Body weight
Bridged Bicyclo Compounds, Heterocyclic
Chronic kidney disease
Diabetes Mellitus, Type 2
Ertugliflozin
Estimated glomerular filtration rate
Female
Glycated Hemoglobin A
Glycosuria
Humans
Hypoglycemic Agents
Kidney outcomes
Male
Natriuresis
Renal Insufficiency, Chronic
SGLT2 inhibitor
Sodium-Glucose Transporter 2 Inhibitors
Sodium–glucose cotransporter 2 inhibitor
Uric Acid
adverse event
antidiabetic agent
biological marker
body weight
cardiovascular disease
chronic kidney failure
complication
controlled study
diabetic nephropathy
Loading...